NCT02071758View on ClinicalTrials.gov

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Visceral Leishmaniasis
Interventions
BIOLOGICAL

LEISH-F3 + SLA-SE

BIOLOGICAL

LEISH-F3 + GLA-SE

Trial Locations (1)

32117

Covance, Inc., Daytona Beach

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Access to Advanced Health Institute (AAHI)

OTHER

NCT02071758 - Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter